CLS
CELESTICA INC
NYSE · CIK 1030894
Last close387.32
Daily change+14.23 (3.81%)
10 Years gain+3476.36%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CLS · STANDARD
SIC 3672 · Printed Circuit Boards · Fiscal year end 1231
Fundamental
79.4Momentum
67.8Acceleration
67.8Confidence
85.0Annual Revenue4
Quarterly Revenue8
Annual CFO4
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.7 / 25
Quality12.5 / 25
Capital Efficiency20.0 / 20
Balance Sheet12.7 / 15
Shareholder Economics8.2 / 10
Forward Indicators2.3 / 5
Signals
Gross margin expansionGross margin improved by 1.783 percentage points.
Operating leverageOperating margin improved by 3.562 percentage points.
FCF growthFree cash flow grew 60.4721%.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.5988%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM52.15%OK
Revenue CAGR 3Y19.56%OK
Gross Margin12.15%OK
Operating Margin8.95%OK
FCF Margin3.25%OK
FCF Growth60.47%OK
ROIC69.53%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-0.51xOK
Diluted Share Growth 1Y-0.6%OK
SBC / Revenue0.54%OK
SBC / FCF16.7%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $12.39B | $1.49B | $1.04B | $659.50M | $458.30M | 12.06% | 8.4% | 3.7% | 56.97% | 116.2M |
| 2025 FY Dec 31, 2024 | $9.65B | $1.03B | $599.30M | $473.90M | $303.00M | 10.72% | 6.21% | 3.14% | 33.55% | 118.7M |
| 2025 FY Dec 31, 2023 | $7.96B | $754.10M | $338.30M | $326.20M | $201.10M | 9.47% | 4.25% | 2.53% | 20% | 120.3M |
| 2024 FY Dec 31, 2022 | $7.25B | $649.70M | $289.30M | $211.10M | $102.10M | 8.96% | 3.99% | 1.41% | n/a | 123.6M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $14.83B | sum latest 4 fiscal quarters Revenue | OK | 0001030894-26-000044, 0001030894-25-000053 |
| Revenue Growth TTM | 52.15% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001030894-26-000044, 0001030894-25-000053 |
| Revenue CAGR 3Y | 19.56% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001030894-26-000011 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001030894-26-000011 |
| Gross Profit CAGR 3Y | 31.99% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001030894-26-000011 |
| Operating Income Growth | 152.69% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001030894-26-000044, 0001030894-25-000053 |
| FCF Growth | 60.47% | FCF_current / FCF_prior_year - 1 | OK | 0001030894-26-000044, 0001030894-25-000053 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 12.15% | Gross Profit / Revenue | OK | 0001030894-26-000044, 0001030894-25-000053 |
| Operating Margin | 8.95% | Operating Income / Revenue | OK | 0001030894-26-000044, 0001030894-25-000053 |
| FCF Margin | 3.25% | (CFO - CapEx) / Revenue | OK | 0001030894-26-000044, 0001030894-25-000053 |
| CFO / Net Income | 0.99x | CFO / Net Income | OK | 0001030894-26-000044, 0001030894-25-000053 |
| FCF / Net Income | 0.46x | FCF / Net Income | OK | 0001030894-26-000044, 0001030894-25-000053 |
| ROIC | 69.53% | NOPAT / Average Invested Capital | OK | 0001030894-26-000044, 0001030894-25-000053 |
| Net Debt / CFO | -0.51x | Net Debt / CFO | OK | 0001030894-26-000044, 0001030894-25-000053 |